Study on Mavorixafor for Patients with Chronic Neutropenia Experiencing Recurrent or Serious Infections
- Substances:Mavorixafor
Greece- Participants:0–17 years · 18–64 years · 65+ years
- Substances:Mavorixafor
- Sponsor:X4 Pharmaceuticals Inc.
Rare diseases
Investigational molecules
Locations
Back to Greece260 clinical trials in Patras, Greece across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
GreeceStudy on the Effects of Iptacopan in Patients with Generalized Myasthenia Gravis
GreeceStudy on the Effects of Zasocitinib for Patients with Moderate to Severe Crohn's Disease
GreeceStudy on the Effects of Iptacopan in Patients with Idiopathic Membranoproliferative Glomerulonephritis (IC-MPGN)
GreeceStudy on Anakinra for Patients with Long COVID and Ongoing Respiratory Symptoms
GreeceStudy on Optimizing CDK 4/6 Inhibitors and Endocrine Therapy for Older Patients with Advanced Breast Cancer Using Abemaciclib, Palbociclib, and Ribociclib
GreeceStudy on the Effectiveness and Safety of Lifileucel and Pembrolizumab for Patients with Untreated, Unresectable, or Metastatic Melanoma
GreeceStudy on Acalabrutinib with Rituximab and Drug Combination for Older Adults with Untreated Diffuse Large B-Cell Lymphoma
GreeceStudy on the Effectiveness and Safety of Indacaterol Acetate/Mometasone Furoate vs. Budesonide for Children Aged 6-11 with Asthma
Greece
GreeceLong-Term Follow-Up Study for Patients Treated with Idecabtagene Vicleucel or Lisocabtagene Maraleucel for Cancer
GreeceStudy Comparing Iberdomide and Lenalidomide for Maintenance Therapy After Stem Cell Transplant in Patients with Newly Diagnosed Multiple Myeloma
GreeceThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Sjögren's Syndrome and Systemic Sclerosis, evaluating novel therapeutic approaches with medications like sibeprenlimab and efgartigimod. These trials aim to improve treatment outcomes for patients with chronic autoimmune disorders.
Studies are exploring both long-term safety and immediate efficacy of new treatment options.
Comprehensive studies in Multiple Myeloma and advanced cancers, including trials of combination therapies and novel treatments. Research includes investigations into treatments for newly diagnosed and relapsed/refractory cases.
Focus on improving patient outcomes through targeted and combination therapies.
Groundbreaking research in Amyotrophic Lateral Sclerosis and Myasthenia Gravis, evaluating innovative treatments and therapeutic approaches for these challenging neurological conditions.
Studies are examining both disease progression and symptom management.
Tell us about your condition – we search every trial in Europe and connect you with the right site.